转染色体牛产生的全人免疫球蛋白G治疗感染埃博拉病毒Makona分离株的非人灵长类动物
转染色体牛经埃博拉病毒Makona分离株糖蛋白纳米颗粒疫苗超免疫后,从其血浆中纯化出抗埃博拉病毒IgG免疫球蛋白(统称SAB-139)。SAB-139在体外可激活自然杀伤细胞、单核细胞和外周血单个核细胞,表面等离子共振显示高结合亲和力。感染Makona-C05的恒河猴在感染后1天(n=6)或3天(n=6)接受足量SAB-139治疗后全部存活,对照组存活率为0%。
要点
- 转染色体牛可产生病原体特异性全人IgG抗体。
- SAB-139在体外激活NK细胞、单核细胞和PBMC,具高结合亲和力。
- 感染后1天或3天给予足量SAB-139的恒河猴全部存活,对照组0%存活。
核心结论
- 本研究证明转染色体牛可产生病原体特异性人免疫球蛋白,用于在新发传染病威胁或流行时预防和/或治疗患者。
研究设计与样本
- 转染色体牛经埃博拉病毒Makona分离株糖蛋白纳米颗粒疫苗序贯超免疫后,从血浆中纯化抗埃博拉病毒IgG免疫球蛋白(统称SAB-139)。
- SAB-139经多种体外生产、研究和临床级检测,使用野生型Makona-C05或不同埃博拉病毒变异株的重组病毒/抗原进行表征。
- 感染埃博拉病毒/H.sapiens-tc/GIN/2014/Makona-C05的恒河猴在感染后1天(n=6)或3天(n=6)接受足量SAB-139治疗,对照组存活率为0%。
主要发现
- SAB-139有效激活自然杀伤细胞、单核细胞和外周血单个核细胞。
- 表面等离子共振显示SAB-139具有高结合亲和力。
- SAB-139的半乳糖-α-1,3-半乳糖碳水化合物浓度与人源静脉注射免疫球蛋白相似,IgG1亚类抗体占主导。
- 感染后1天(n=6)或3天(n=6)接受足量SAB-139治疗的恒河猴全部存活,对照组存活率为0%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transchromosomic bovines (Tc-bovines) adaptively produce fully human polyclonal immunoglobulin (Ig)G antibodies after exposure to immunogenic antigen(s). The National Interagency Confederation for Biological Research and collaborators rapidly produced and then evaluated anti-Ebola virus IgG immunoglobulins (collectively termed SAB-139) purified from Tc-bovine plasma after sequential hyperimmunization with an Ebola virus Makona isolate glycoprotein nanoparticle vaccine. SAB-139 was characterized by several in vitro production, research, and clinical level assays using wild-type Makona-C05 or recombinant virus/antigens from different Ebola virus variants. SAB-139 potently activates natural killer cells, monocytes, and peripheral blood mononuclear cells and has high-binding avidity demonstrated by surface plasmon resonance. SAB-139 has similar concentrations of galactose-α-1,3-galactose carbohydrates compared with human-derived intravenous Ig, and the IgG1 subclass antibody is predominant. All rhesus macaques infected with Ebola virus/H.sapiens-tc/GIN/2014/Makona-C05 and treated with sufficient SAB-139 at 1 day (n = 6) or 3 days (n = 6) postinfection survived versus 0% of controls. This study demonstrates that Tc-bovines can produce pathogen-specific human Ig to prevent and/or treat patients when an emerging infectious disease either threatens to or becomes an epidemic.
引用
- Luke T, Bennett RS, Gerhardt DM, et al. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate. J Infect Dis. 2018. PMID: 30010950. doi:10.1093/infdis/jiy377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。